RegisterLogin

EVER2 Antibody

CAT: 223-4605-01Size: 0.02 mgDry Ice: NoHazardous: No
0.02 mgSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Background
EVER2 Antibody: Epidermodysplasia verruciformis (EV) is an autosomal recessive genodermatosis associated with a high risk of skin cancers resulting from a high susceptibility to infection by specific human papillomaviruses. Mutations in two homologous genes EVER1 and EVER2 cause the majority of EV cases. These two proteins form a complex and interact with the zinc transporter ZnT-1 in the endoplasmic reticulum. Cells lacking EVER2 accumulated higher levels of zinc in the nucleolus and nucleus compare to those cells with and intact EVER2 gene, indicating that one role of EVER2 is to regulate the intracellular distribution of zinc.
NCBI Gene ID
147138
Swiss Prot
Q8IU68
Accession Number
AAM44454
Host
Rabbit
Reactivity
Human, Mouse, Rat
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Homeostasis
Purification
EVER2 Antibody is affinity chromatography purified via peptide column.
Positive Control
Cat. No. 1205 - Jurkat Cell Lysate
Concentration
1 mg/mL
Buffer
EVER2 Antibody is supplied in PBS containing 0.02% sodium azide.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
EVER2 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Fragment
IgG
Specificity
At least three isoforms of EVER2 are known to exist; this antibody will only recognize the larger isoform. EVER2 has no cross-reactivity to EVER1.
Symbol
TMC8
Positive Control 2
Cat. No. 10-301 - Human Brain Tissue Slide
NCBI Official Name
Transmembrane channel-like 8
NCBI Organism
Homo sapiens
Background Reference 01
Ramoz N, Taieb A, Rueda L-A, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J. Invest. Dermatol.2000; 114:1148-53.
Background Reference 02
Ramoz N, Rueda L-A, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet.2002; 32:579-81.
Background Reference 03
Lazarczyk M, Pons C, Mendoza J-A, et al. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med.2008; 205:35-42.
Other Product Names
EVER2 Antibody: EV2, EVER2, EVIN2, Transmembrane channel-like protein 8, Epidermodysplasia verruciformis protein 2
Tested Applications
ELISA, WB, IHC-P, IF
Protein ID
25527192
Physical Properties
Liquid

Related Products

CatalogName
4605PEVER2 Peptide
4657PEVER2 Peptide
4547-01mgEVER1 Antibody
4547-002mgEVER1 Antibody
4547-01EVER1 Antibody
4549-01EVER1 Antibody
4549-01mgEVER1 Antibody
4549-002mgEVER1 Antibody
4549PEVER1 Peptide
4547PEVER1 Peptide

Alternative Products

CatalogName
MBS150620-01EVER2 Antibody
OAPB00679-100UGEVER2 Antibody
MBS9412372-01EVER2 Antibody
253874EVER2 Antibody
MBS150490-01EVER2 Antibody
24683EVER2 Antibody
24707EVER2 Antibody
MBS9414312-01EVER2 Antibody
253897EVER2 Antibody
OAPB00703-100UGEVER2 Antibody

Popular Products